Technology – Call it bad timing or just bad luck. The Omicron variant rained on the CES 2022 parade. Again. Still, the Las Vegas fair went bravely ahead, respecting all safety measures to ensure healthy explorations into near and visionary futures. With over 2.300 exhibitors present, audiences worldwide can now see how technology supports, engages, and keeps us safe in a reimagined world.
- RELATED STORIES: Read more about CES 2022 on Archipanic…
Despite major companies, press outlets, and other attendees canceling their trips to Vegas, ground-breaking tech brands and startups launched products featuring innovation across artificial intelligence, automotive technology, digital health, smart home and more. Check our report featuring multi-sensorial AI-powered innovation.
As usual, tellies and phones grew bigger and cooler while a horde of robots and droids starred. Ameca stole the show, the humanoid-bot and AI-creature by British company Engineered Arts is able to replicate hyper-realistic and convincing facial expressions.
Automotive is king at CES. Among the highlights are BMW’s color-changing car and the first self-driving truck by John Deere. The autonomous tractor will be available to farmers later this year and comes with six pairs of stereo cameras, enabling a less than 1-inch precision while in motion.
GM – General Motors announced the Chevrolet Silverado EV, an electric version of its iconic pickup truck. Designed as an EV from the ground up, the Silverado EV will offer 400 miles of range on a single charge and feature GM’s Ultium battery packs. Sony announced and exhibited an SUV-type prototype vehicle (VISION-S 02) as a new form factor.
Who said that innovation is in the hands of blokes? The Consumer Technology Association (CTA)® and the World Bank Group announced the Global Women’s HealthTech Awards winners, recognizing innovative startups that leverage tech to improve women’s health and safety in emerging markets.
Antiva Biosciences developed novel, topical therapeutics to treat pre-cancerous lesions caused by HPV before they progress to invasive cancers. InnAccel has developed an AI-powered fetal heart rate monitor for mothers in labor or post 36 weeks of gestation, reducing intrapartum deaths through better diagnosis and more effective care. NIRAMAI has developed a novel low cost and accurate software-based medical device to detect early-stage breast cancer in a simple and private way. UE LifeSciences has developed iBreastExam, a radiation-free device that enables earlier stage detection of breast cancer at low-cost and minimal training compared to other options.
Photos: courtesy of CES 2022 or the exhibitors.